Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis
about
Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis
description
scientific article published on 11 March 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2019
@uk
name
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@en
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@nl
type
label
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@en
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@nl
prefLabel
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@en
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@nl
P2093
P921
P1433
P1476
Daclizumab: Mechanisms of Acti ...... r Relapsing Multiple Sclerosis
@en
P2093
Elisabeth B Lucassen
Meghan C Romba
Stanley L Cohan
P356
10.3390/BIOMEDICINES7010018
P407
P577
2019-03-11T00:00:00Z